Leukemia Research and Treatment

Table of Contents

Table of Contents

  • Leukemia Research and Treatment -
  • Special Issue
  • Volume 2012
  • - Article ID 250432
  • - Research Article

Factor V Leiden and Prothrombin 20210A Mutations among Turkish Pediatric Leukemia Patients

Dilara Fatma Akın | Kadir Sipahi | ... | Nejat Akar
  • Leukemia Research and Treatment -
  • Special Issue
  • Volume 2012
  • - Article ID 150651
  • - Research Article

Identification of a Novel P190-Derived Breakpoint Peptide Suitable for Peptide Vaccine Therapeutic Approach in Ph+ Acute Lymphoblastic Leukemia Patients

Micaela Ippoliti | Marzia Defina | ... | Monica Bocchia
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 932175
  • - Review Article

Clinical Trials of Adult T-Cell Leukaemia/Lymphoma Treatment

Ambroise Marçais | Felipe Suarez | ... | Olivier Hermine
  • Leukemia Research and Treatment -
  • Special Issue
  • Volume 2012
  • - Article ID 179402
  • - Review Article

Important Genes in the Pathogenesis of 5q- Syndrome and Their Connection with Ribosomal Stress and the Innate Immune System Pathway

Ota Fuchs
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 984754
  • - Review Article

Cotranscriptional Chromatin Remodeling by Small RNA Species: An HTLV-1 Perspective

Nishat Aliya | Saifur Rahman | ... | Pooja Jain
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 259045
  • - Review Article

Immunopathogenesis of Human T-Cell Leukemia Virus Type-1-Associated Myelopathy/Tropical Spastic Paraparesis: Recent Perspectives

Mineki Saito | Charles R. M. Bangham
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 101754
  • - Review Article

Clinical Trials and Treatment of ATL

Kunihiro Tsukasaki | Kensei Tobinai
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 876153
  • - Review Article

Comparison of the Genetic Organization, Expression Strategies and Oncogenic Potential of HTLV-1 and HTLV-2

Francesca Rende | Ilaria Cavallari | ... | Vincenzo Ciminale
  • Leukemia Research and Treatment -
  • Special Issue
  • Volume 2011
  • - Article ID 329572
  • - Review Article

Understanding and Targeting the Wnt/β-Catenin Signaling Pathway in Chronic Leukemia

S. Thanendrarajan | Y. Kim | I. G. H. Schmidt-Wolf
  • Leukemia Research and Treatment -
  • Special Issue
  • Volume 2011
  • - Article ID 428960
  • - Review Article

Wnt/ß-Catenin: A New Therapeutic Approach to Acute Myeloid Leukemia

Y. Kim | S. Thanendrarajan | I. G. H. Schmidt-Wolf
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 128617
  • - Review Article

Pathogenesis of Metastatic Calcification and Acute Pancreatitis in Adult T-Cell Leukemia under Hypercalcemic State

Masachika Senba | Kioko Kawai | Naoki Mori
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 391953
  • - Review Article

Is There a Role for HTLV-1-Specific CTL in Adult T-Cell Leukemia/Lymphoma?

Aileen G. Rowan | Charles R. M. Bangham
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 213653
  • - Review Article

Molecular and Cellular Mechanism of Leukemogenesis of ATL: Emergent Evidence of a Significant Role for HBZ in HTLV-1-Induced Pathogenesis

Yorifumi Satou | Masao Matsuoka
  • Leukemia Research and Treatment -
  • Special Issue
  • Volume 2011
  • - Article ID 726964
  • - Review Article

Characterization of Kaposi's Sarcoma-Associated Herpesvirus-Related Lymphomas by DNA Microarray Analysis

Keiji Ueda | Eriko Ohsaki | ... | Xin Zheng
  • Leukemia Research and Treatment -
  • Special Issue
  • - Volume 2012
  • - Article ID 262363
  • - Clinical Study

Diffuse Large B-Cell Lymphoma in Human T-Lymphotropic Virus Type 1 Carriers

Brady E. Beltran | Pilar Quiñones | ... | Jorge J. Castillo

We have begun to integrate the 200+ Hindawi journals into Wiley’s journal portfolio. You can find out more about how this benefits our journal communities on our FAQ.